You have access
Combined Therapy of ATRA and Imatinib Mesylate Decreases BCR-ABL and ABCB1/MDR1 Expression Through Cellular Differentiation in a Chronic Myeloid Leukemia Model
CAMILA ALBUQUERQUE PINTO, ADRHYANN JULLYANNE DE SOUSA PORTILHO, MARITZA CAVALCANTE BARBOSA, MARIA ELISABETE AMARAL DE MORAES, JOSÉ ALEXANDRE RODRIGUES DE LEMOS, ROMMEL MΑRIO RODRIGUEZ BURBANO and CAROLINE AQUINO MOREIRA-NUNES
In Vivo September 2021, 35 (5) 2661-2667; DOI: https://doi.org/10.21873/invivo.12549